Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
  1. 4 Open-market sale Chief Medical Officer sold 6,097 shares at $8.30 ($50,601)
  2. 4 Open-market sale Chief Operating Officer sold 847 shares at $7.38 ($6,253)
  3. 4 Planned sale Chief Financial Officer sold 4,701 shares at $7.78 ($36,588)
  4. 4 Planned sale Chief Executive Officer sold 13,871 shares at $7.78 ($107,952)
  5. 4 Open-market sale Chief Medical Officer sold 3,285 shares at $8.09 ($26,575)
  6. 4 Open-market sale Chief Operating Officer sold 2,415 shares at $8.09 ($19,537)
  7. 4 Grant or award Chief Medical Officer acquired 28,365 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 28,082 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
  10. 4 Grant or award Chief Operating Officer acquired 28,365 shares (grant or award)
  11. 4 Open-market sale 10% owner sold 30,029 shares at $11.46 ($344,012)
  12. 4 Planned sale Chief Executive Officer sold 27,633 shares at an average $17.05 ($471,204)
  13. 4 Planned sale Chief Financial Officer sold 12,981 shares at $17.02 ($220,937)
  14. 4 Planned sale Director sold 1,060 shares at $20.50 ($21,730)
  15. 4 Grant or award Director acquired 4,800 shares (grant or award)
  16. 4 Planned sale Director sold 2,783 shares at $7.35 ($20,465)
  17. 4 Grant or award Director acquired 4,800 shares (grant or award)
  18. 4 Planned sale Director sold 1,392 shares at $7.25 ($10,096)
  19. 4 Grant or award Director acquired 4,800 shares (grant or award)
  20. 4 Grant or award Director acquired 4,800 shares (grant or award)

Page 2 of 17 · 340 filings